» Articles » PMID: 26652024

WNT5A Transforms Intestinal CD8αα⁺ IELs into an Unconventional Phenotype with Pro-inflammatory Features

Overview
Publisher Biomed Central
Specialty Gastroenterology
Date 2015 Dec 15
PMID 26652024
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intestinal intraepithelial lymphocytes that reside within the epithelium of the intestine form one of the main branches of the immune system. A majority of IELs express CD8α homodimer together with other molecules associated with immune regulation. Growing evidence points to the WNT signaling pathway as a pivotal piece in the immune balance and focuses on its direct regulation in intestinal epithelium. Therefore we decided to investigate its role in IELs' immune status determination.

Method: DSS colitis was induced in male C57BL mice. IELs were isolated from colon samples using mechanical dissociation followed by percoll gradient purification and Magnetic-activated cell sorting. Phenotype and cytokine production and condition with Wnts were analyzed by flow cytometry, real-time PCR or ELISA. Proliferation of lymphocytes were evaluated using CFSE dilution. Cell responses after WNT pathway interference were also evaluated.

Results: Non-canonical WNT pathway elements represented by FZD5, WNT5A and NFATc1 were remarkably elevated in colitis IELs. The non-canonical WNT5A skewed them into a pro-inflammatory category as measured by inhibitory cell surface marker LAG3, LY49E, NKG2A and activated marker CD69 and FASL. Gaining of a pro-inflammatory marker was correlated with increased IFN-γ production but not TNF whilst decreased TGF-β and IL-10. Both interrupting WNT5A/PKC pathway and adding canonical WNT stimulants could curtail its immune-activating effect.

Conclusion: Canonical and non-canonical WNT signals act in opposing manners concerning determining CD8αα(+) IELs immune status. Targeting non-canonical WNT pathway may be promising in tackling inflammatory bowel disease.

Citing Articles

From bench to bedside: targeting lymphocyte activation gene 3 as a therapeutic strategy for autoimmune diseases.

Zhou X, Gu Y, Wang H, Zhou W, Zou L, Li S Inflamm Res. 2023; 72(6):1215-1235.

PMID: 37314518 DOI: 10.1007/s00011-023-01742-y.


Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis.

Kotsafti A, DInca R, Scarpa M, Fassan M, Angriman I, Mescoli C Clin Transl Gastroenterol. 2019; 10(7):e00061.

PMID: 31343468 PMC: 6708661. DOI: 10.14309/ctg.0000000000000061.

References
1.
Di Liddo R, Bertalot T, Schuster A, Schrenk S, Tasso A, Zanusso I . Anti-inflammatory activity of Wnt signaling in enteric nervous system: in vitro preliminary evidences in rat primary cultures. J Neuroinflammation. 2015; 12:23. PMC: 4332439. DOI: 10.1186/s12974-015-0248-1. View

2.
Bhagat G, Naiyer A, Shah J, Harper J, Jabri B, Wang T . Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J Clin Invest. 2007; 118(1):281-93. PMC: 2117760. DOI: 10.1172/JCI30989. View

3.
He X, Koenen H, Smeets R, Keijsers R, van Rijssen E, Koerber A . Targeting PKC in human T cells using sotrastaurin (AEB071) preserves regulatory T cells and prevents IL-17 production. J Invest Dermatol. 2013; 134(4):975-983. DOI: 10.1038/jid.2013.459. View

4.
Ma J, Wang R, Fang X, Sun Z . β-catenin/TCF-1 pathway in T cell development and differentiation. J Neuroimmune Pharmacol. 2012; 7(4):750-62. PMC: 3582214. DOI: 10.1007/s11481-012-9367-y. View

5.
Keerthivasan S, Aghajani K, Dose M, Molinero L, Khan M, Venkateswaran V . β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells. Sci Transl Med. 2014; 6(225):225ra28. PMC: 4020714. DOI: 10.1126/scitranslmed.3007607. View